[Diagnosis and treatment of pneumocystis jirovecii pneumonia]

MeSH terms

• AIDS-Related Opportunistic Infections / diagnosis
• AIDS-Related Opportunistic Infections / drug therapy
• AIDS-Related Opportunistic Infections / pathology
• Anti-Infective Agents / adverse effects
• Anti-Infective Agents / therapeutic use
• Antifungal Agents / adverse effects
• Antifungal Agents / therapeutic use
• Atovaquone / adverse effects
• Atovaquone / therapeutic use
• Bronchoalveolar Lavage Fluid / microbiology
• Caspofungin
• Diagnosis, Differential
• Echinocandins / adverse effects
• Echinocandins / therapeutic use
• Humans
• Lipopeptides
• Lung / pathology
• Opportunistic Infections / diagnosis
• Opportunistic Infections / drug therapy
• Opportunistic Infections / pathology
• Pentamidine / adverse effects
• Pentamidine / therapeutic use
• Pneumocystis carinii*
• Pneumonia, Pneumocystis / diagnosis*
• Pneumonia, Pneumocystis / drug therapy
• Pneumonia, Pneumocystis / pathology
• Tomography, X-Ray Computed
• Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects
• Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
• Trimetrexate / adverse effects
• Trimetrexate / therapeutic use